@[email protected] to News • 7 months agoFDA’s review of MDMA for PTSD highlights study bias and safety concernsarstechnica.comexternal-linkmessage-square33fedilinkarrow-up1165arrow-down111cross-posted to: [email protected]
arrow-up1154arrow-down1external-linkFDA’s review of MDMA for PTSD highlights study bias and safety concernsarstechnica.com@[email protected] to News • 7 months agomessage-square33fedilinkcross-posted to: [email protected]
Peer review is important.